Catalog Number 383328 |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Erythema (1840); Fever (1858); Unspecified Infection (1930); Swelling (2091)
|
Event Date 10/28/2019 |
Event Type
Injury
|
Manufacturer Narrative
|
Date of event: unknown.The date received by manufacturer has been used for this field.There were multiple lot numbers reported to be involved.The information for each lot number is as follows: medical device lot #: 8290668; medical device expiration date: 2022-09-30; device manufacture date: 2018-11-30; medical device lot #: 8334770; medical device expiration date: 2022-11-30; device manufacture date: 2019-01-03; a device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
|
|
Event Description
|
It was reported that the patient sustained a "cellulite infection" after the bd saf-t-intima¿ iv catheter safety system was used on them.The symptoms included "redness, fever, and swelling in the insertion site", and treatment had to be stopped so antibiotics could be used to treat the infection.Lot #'s 8290668 and 8334770 were reported to have been involved in this event, but it is unknown how many occurrences happened within each lot.This complaint was created to capture the 1st of 3 related incidents.The following information was provided by the initial reporter: "cellulite infection after using sc saf-t-intima, involving redness, fever, and swelling in the insertion site, in one patient it appears on the same day and in two patients after 3-4 days.The patients needed antibiotics for treating the infection"."stop treatment and start antibiotics course".
|
|
Manufacturer Narrative
|
Investigation summary: a device history review was conducted for lot numbers 8290668 & 8334770.Our records show that this is the first instance of this issue occurring in either production batch.According to the sampling plan applied for product performance, these lots were accepted and released without defects being noted during the final assembly or visual inspections.Additionally, a sample could not be obtained for evaluation and testing, but this lot was treated and received a certificate of conformance for sterility.Without the ability to investigate the affected unit our quality engineers were unable to determine the root cause for this complaint.
|
|
Event Description
|
It was reported that the patient sustained a "cellulite infection" after the bd saf-t-intima¿ iv catheter safety system was used on them.The symptoms included "redness, fever, and swelling in the insertion site", and treatment had to be stopped so antibiotics could be used to treat the infection.Lot #'s 8290668 and 8334770 were reported to have been involved in this event, but it is unknown how many occurrences happened within each lot.This complaint was created to capture the 1st of 3 related incidents.The following information was provided by the initial reporter: "cellulite infection after using sc saf-t-intima, involving redness, fever, and swelling in the insertion site, in one patient it appears on the same day and in two patients after 3-4 days.The patients needed antibiotics for treating the infection." "stop treatment and start antibiotics course.".
|
|
Search Alerts/Recalls
|
|